5NCF
ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-4]-OH
Summary for 5NCF
Entry DOI | 10.2210/pdb5ncf/pdb |
Descriptor | Protein enabled homolog, (1~{S},4~{S},7~{R},10~{R})-14-[(3~{S},6~{R},8~{a}~{S})-1'-[(2~{S})-2-acetamido-3-(2-chlorophenyl)propanoyl]-5-oxidanylidene-spiro[1,2,3,8~{a}-tetrahydroindolizine-6,2'-pyrrolidine]-3-yl]carbonyl-2-oxidanylidene-3,14-diazatricyclo[8.4.0.0^{3,7}]tetradec-8-ene-4-carboxylic acid, SULFATE ION, ... (6 entities in total) |
Functional Keywords | proline-rich motif, ena/vasp inhibitor, actin, protein-protein interaction, cell adhesion |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 27233.37 |
Authors | Barone, M.,Roske, Y. (deposition date: 2017-03-04, release date: 2017-06-14, Last modification date: 2024-01-31) |
Primary citation | Barone, M.,Muller, M.,Chiha, S.,Ren, J.,Albat, D.,Soicke, A.,Dohmen, S.,Klein, M.,Bruns, J.,van Dinther, M.,Opitz, R.,Lindemann, P.,Beerbaum, M.,Motzny, K.,Roske, Y.,Schmieder, P.,Volkmer, R.,Nazare, M.,Heinemann, U.,Oschkinat, H.,Ten Dijke, P.,Schmalz, H.G.,Kuhne, R. Designed nanomolar small-molecule inhibitors of Ena/VASP EVH1 interaction impair invasion and extravasation of breast cancer cells. Proc.Natl.Acad.Sci.USA, 117:29684-29690, 2020 Cited by PubMed: 33184177DOI: 10.1073/pnas.2007213117 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.4 Å) |
Structure validation
Download full validation report